Korea Investment CORP Increases Stock Position in West Pharmaceutical Services, Inc. $WST

robot
摘要生成中

Korea Investment CORP significantly increased its holdings in West Pharmaceutical Services, Inc. (NYSE:WST) by 129.3% during the third quarter, now owning 56,097 shares valued at $14.72 million. Other institutional investors also adjusted their positions in the medical instruments supplier. Analysts have issued a consensus “Buy” rating for WST with an average target price of $314.56, following recent price target adjustments and upgrades. The company reported strong quarterly earnings, surpassing estimates, and declared a quarterly dividend of $0.22 per share.

此頁面可能包含第三方內容,僅供參考(非陳述或保證),不應被視為 Gate 認可其觀點表述,也不得被視為財務或專業建議。詳見聲明
  • 讚賞
  • 留言
  • 轉發
  • 分享
留言
請輸入留言內容
請輸入留言內容
暫無留言